Nesta is an independent non-profit foundation based in London, United Kingdom, founded in 1998 with an endowment from the UK National Lottery. The organization is dedicated to fostering innovation, talent, and creativity to address significant societal challenges. Nesta specializes in making direct and fund of fund investments in a variety of sectors, with a strong emphasis on technology, including engineering, software, healthcare, and cleantech. It invests across different stages, from seed to growth, and prefers to take an active role by securing board seats in its portfolio companies. In addition to its investment activities, Nesta engages in research and practical programs aimed at improving lives and driving social change. The foundation collaborates with various partners to identify and develop transformative ideas that can make a meaningful impact.
Oxford Medical Products is developing a safe, effective and affordable breakthrough technology for weight loss that uses a self-expanding capsule which occupies space in the stomach, reducing hunger and leading to significant weight loss. Led by a team of scientists, medical professionals, and entrepreneurs who have come together to solve one of the world’s toughest and most urgent medical challenges.
Would You Rather Be is an award-winning AI-powered career planning platform that matches people to careers based on their interests, skills and qualifications. Acquired by Learning Curve Group, one of the largest training providers in the UK.
Find Others addresses the increasing need to hold organisations and governments to account for injustices that often impact thousands of individuals, from human rights abuses to privacy breaches.Seeking justice as an individual is daunting and often unattainable. Find Others provides a central hub for victims of injustices to unite and take action. Whether you want to run a campaign, lobby for change or pursue legal action, Find Others gives you the means to do so.We also provide legal professionals with comprehensive tools to efficiently manage group cases, from instigation through to resolution.When we come together we are stronger. Individuals and institutions that were always considered too powerful to hold to account take note, you will no longer be able to intimidate the underdog.
Symetrica Ltd. engages in the development and commercialization of radiation detection and identification systems for security, medical diagnostics, geophysical, and space research and development applications. The company was incorporated in 2002 and is based in Southampton, the United Kingdom.
Voice 21 is a charity dedicated to promoting the value of oracy in education in the schools that need it most. We provide professional and leadership development, school improvement and curriculum resources for teachers and schools.
Sidmouth College is a non-selective secondary school that provides a high standard of education. Their children succeed academically, expand their creative abilities, flourish in athletics, and experience a lot of new things in a welcoming environment.
Children's University is an award winning, critically acclaimed, extra-curricular and informal learning programme which takes education outside the normal school day and environment.Children's University encourage 5-14 year olds to challenge themselves, to try new experiences, to develop new interests and acquire new skills. Delivered at a local level by local partners, Children’s University operates across the British Isles with 125 centres as well as internationally in at least 4 countries with a further 10 expressions of interest.
Mind Moose is an online platform for children to help them develop good mental well-being & early intervention for mental health issues. The company was founded in 2016 and is headquartered in Alderley Edge, Cheshire, United Kingdom.
Franklin Scholars is a social enterprise, and reinvests the majority of its profits to achieve sustainability, grow its reach and ensure the fulfilment of its mission.
MacMillan Academy is an educational facility created to offer classrooms and learning settings for the instruction of students under the guidance of teachers. They support education's transformative potential and work to equip young people with the knowledge, resourcefulness, and creativity they need to face difficulties in the future. They encourage kids to acquire crucial abilities and receive consistent instruction in order to better prepare them for life beyond school.
The Foundation for Positive Mental Health is a charity engaged in promoting skill training for positive mental health. They promote skills training for positive mental health to enhance everyday wellbeing and increase resilience to and recovery from mental health difficulties.
Empathy Lab is a pioneering organization that focuses on enhancing children's empathy, literacy, and social activism through the use of high-quality literature. By leveraging emerging scientific evidence, Empathy Lab emphasizes the role of reading in developing real-life empathy skills. In addition to its educational initiatives, Empathy Lab provides digital strategy and execution services to Fortune 500 companies and fast-growth organizations. The agency is renowned for creating broadband video, eCommerce, and community-driven experiences, offering deep insights into the needs and preferences of end-users through innovative primary research. Its clientele includes notable companies in the media, entertainment, and eCommerce sectors, such as Sony, Comcast, NBC Universal, and the American Red Cross.
Swoop Finance Limited is a technology platform that specializes in business funding and savings solutions for small-to-medium enterprises. Founded in 2018 and headquartered in London, with additional offices in Ireland, Swoop connects businesses with a range of funding options, including loans, equity, and grants. The platform facilitates the discovery of appropriate funding solutions, allowing enterprises to streamline their financing needs and identify potential savings. Swoop operates as an Appointed Representative of Talbot Capital Limited, which is regulated by the Financial Conduct Authority.
At Px, we put patient experience at the heart of delivering better oncology outcomes. With the oncology platform OWise, we have developed evidence-based, accredited mobile apps and web apps for people living with breast or prostate cancer. OWise has been designed to create a systemic change to value-based cancer care by: - Supporting patients with personalized digital technology. - Enabling patients to share health data in real-time with their care teams. - Bridging the evidence gap by supporting health organizations with patient-centric Real-World Insights. As the annual cost of cancer exceeds $1.16 trillion today, we need to address the individual and financial burdens by increasing patients’ wellbeing and significantly improving clinical outcomes while saving health care costs. The award-winning mobile app ‘OWise breast cancer’ has been independently studied, showing that 90% of the patients and 90% of the treating clinicians recommend OWise to breast cancer patients. OWise is designed to support patients as part of their everyday life during treatment. OWise has been selected by the NHS Innovation Accelerator (2015) to fast-track adoption, it was listed in the Top25 of all health apps (IQVIA, 2017) and has won numerous prizes and awards since (see https://owise.uk/our-science). Px applies advanced data-analytics to the anonymised, real-world patient-reported outcome (PRO) data providing real-time feedback to patients designed to improve both quality of life and overall survival. On a population scale, insights into the OWise PRO data, which are commercialised to health care providers and payers, are aimed at improving both cancer outcomes and cost-effectiveness globally. With our main product OWise, we have developed the best-in-class mobile app to support cancer patients during treatment. OWise is now recognised as the key, patient-driven cancer support platform that combines improving - patient experience, - clinical outcomes, and - cancer care cost-effectiveness.
Citymart powers cities to deliver services that work. Following best practices developed with leading cities around the world, Citymart connects cities and revolutionizes the way cities frame needs, complete procurements, and improve service delivery. Over 100 cities in 35 countries have adopted Citymart tools and methods to-date.
Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countries to prevent fraud and financial crime. ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.
Radio Physics Solutions is a security and investigation company that specializes in the fields of real-time concealed threat detection, Up to 30m Distance, autonomous, and unobtrusive. It specializes in providing early warning of threats concealed under peoples’ clothes, and so reduce the number of casualties caused by terrorists and criminals globally at schools, train stations, airports, government and military installations, tourist attractions and entertainment venues. Radio Physics Solutions was founded in 2009 and headquartered in Cambridgeshire, United Kingdom.
Orthogem develops and manufactures synthetic bone grafts. Its patented Tripore technology platform has enabled the creation of a pipeline of SBG's formulated for a variety of clinical applications, ranging from spinal to oral cranial facial surgery. Orthogem's products include TriPore Granules, TriPore MPA, and TriPore Blocks. Wei Lo founded it in 2001, with its headquarters in Nottingham in the United Kingdom.
Plaxica is a technology and licensing company focused on the production of next generation biopolymers and platform chemicals from renewable resources. It was founded in 2008 and is based in London and Wilton.
Veryan was formed in 2003 as the result of a technology spin out from Imperial College, London, UK. Veryan has designed, patented and developed a highly innovative three dimensional (3D) Nitinol (nickel-titanium alloy) stent technology – BioMimics 3D – based on the pioneering work by Professor Colin Caro (Emeritus Professor of Physiological Mechanics, Dept. of Bioengineering, Imperial College London) on the link between vessel geometry, blood flow mechanics and vascular disease.
Probe Scientific is developing innovative products to solve clinical problems and improve healthcare. The company has a substantial product pipeline based on its proprietary technologies and is seeking to commercialise this range to simultaneously benefit clinicians and the community in general. Probe Scientific Ltd is a private company, founded in 1998 and is based in the West Midlands, UK. Probe Scientific has grown steadily since its origins as a research organisation and has recently recruited experienced senior executives with a commercial focus.
Smart Surgical Appliances
Venture Round in 2017
Smart Surgical Appliances is a medical device company that develops sensor-enabled surgical instruments designed to reduce costs, improve safety, and minimize risk in keyhole surgery. The company intends to improve the safety and clinical efficacy of the minimally invasive surgery like keyhole surgery, endoscopic surgery, and the natural orifice transluminal endoscopic surgeries. It provide real-time sensing and feedback from the operative site akin to 'touch and feel'.
designLED is an internationally recognized company specializing in LED lighting systems and technology, primarily serving the automotive industry. Founded in 2004, the company focuses on designing and developing innovative lighting and human-machine interface (HMI) products that meet the growing global demand for low-energy and cost-effective lighting solutions. Their offerings include customizable optics integrated with flexible light tiles, allowing for versatility in applications such as directional lighting and backlighting. By leveraging advanced technologies and strategic partnerships, designLED aims to transform lighting products and enhance their functionality in diverse environments, aligning with global trends and regulations that prioritize energy efficiency and sustainability.
Symetrica Ltd. engages in the development and commercialization of radiation detection and identification systems for security, medical diagnostics, geophysical, and space research and development applications. The company was incorporated in 2002 and is based in Southampton, the United Kingdom.
CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga. The programme also has potential clinical utility in non-small cell lung, breast and colon cancer.
Lein Applied Diagnostics is an optical metrology company pioneering measurement devices and solutions for the healthcare and industrial markets. Its core technology is based around a scanning confocal system that can make highly precise, non-contact dimensional and structural measurements of organic and man-made materials. Lein was founded in 2003, initially to develop a non-invasive, pain free glucose meter for the diabetes market. Underpinning this Lein put together a highly qualified, experienced engineering team and built up a strong suite of patents.
Cytox have developed a simple genetic based blood test for the assessment of risk and diagnosis of Alzheimer's Disease in the very early stages. Alzheimer's Disease affects over 26 million people world-wide and is a growing condition as people live longer. There is currently no cure for Alzheimer's Disease, but there are large international initiatives underway to find treatments with many drugs in clinical development. Cytox are commercially launching their tests in conjunction with Affymetrix (part of Thermo Fisher Scientific) to support Pharmaceutical and Biotechnology companies developing novel therapeutics.
Playmob is a game platform for brands with a purpose. They connect the most meaningful brands to billions of mobile gamers, to take action and make the world a better place while positively boosting the brand's bottom line.
Using novel metal alloys and magnetic fields Camfridge is creating a new generation of low carbon cooling products that will dramatically reduce energy consumption and use no polluting gases. Camfridge was selected as part of the Cleantech 100 - one of the top 100 private European clean technology companies.
Dialog Devices develops optical technologies to help meet the overwhelming demand for better healthcare. Its advanced opto-electronic technology is revolutionizing the way medical conditions are diagnosed and monitored; improving the health and well-being of people around the world. The company is also advancing additional applications for this technology including post-operative monitoring of peripheral interventions and diabetic neuropathy assessment.
Agilent Raman Spectroscopy’s proprietary technologies use novel variants of Raman spectroscopy. Their instruments can rapidly and accurately identify materials hidden inside objects or through opaque barriers such as plastic, coloured glass, paper and skin, or can measure the concentrations of materials in mixtures, with a high degree of accuracy. Agilent Raman Spectroscopy is formerly known as Cobalt Light Systems and is part of Agilent.
Ashe Morris
Venture Round in 2017
Ashe Morris is developing a heat transfer technology that helps improve the efficiency of industrial processes and reduce energy consumption.
BaseKit is the most widely deployed website editor distributed by hosting, telco and internet companies. Their hosting partners benefit from improved ARPU, reduced churn and higher customer satisfaction ratings. Supported configurations include On-premise, SaaS, cPanel plugin and Parallels APS. Their application and documentation is available in 16 languages.
Surface Generation is a privately-owned high technology and manufacturing company headquartered in the UK and with facilities in North America and Asia. Its patented Production to Functional Specification (PtFS) technology enables manufacturers in the aerospace, automotive and consumer electronics sectors to work with composite materials, saving costs, energy and producing significantly lighter weight products.
Six to Start is an independent game developer based in London, specializing in story-like games and game-like stories. Their latest games include Zombies, Run!, the world's bestselling smartphone fitness app, and The Walk, the first smartphone fitness game funded by the UK's Department of Health.
ProKyma develops cell separation technology to improve molecular biology tests. ProKyma’s own focus lies in developing an improved blood test for Circulating Tumour Cells (CTC's) to improve detection of early metastasis of cancers and subsequent monitoring of the response to therapy. The company is a spinout from Dstl Porton Down, to exploit Dstl’s research into separation technologies. The company’s expertise lies in the use of high frequency ultrasound along with magnetism to manipulate, concentrate, and purify biological cells from complex samples – a technique that has diverse applications in the clinical, food, environmental, and pharmaceutical sectors.
eoSemi is an emerging privately-funded semiconductor product company based in South Yorkshire. Shrinking electronic systems are placing significant pressure on traditional timing and frequency devices to reduce in size without compromising performance - something they cannot do easily or cheaply. eoSemi is a new technological transformation. It meets head-on the challenges of size-vs-performance, with an enabling technology that allows for creation of far more compact designs, and that facilitates new classes of product and application.
Kaptivo uses AI to make visual collaboration easier and more efficient. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. Businesses and schools use Kaptivo in conjunction with Zoom, Cisco Webex, Microsoft Teams, Slack and other collaboration tools to improve productivity while keeping content secure.
Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countries to prevent fraud and financial crime. ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.
Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countries to prevent fraud and financial crime. ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.
The Behavioural Insights Team is an organisation that was set up to apply nudge theory to try to improve government policy and services. The company itself has three owners: the employees, the UK government, and Nesta (the UK's leading innovation charity). Nesta were the winners of a highly competitive process to become the team's joint venture partners, and we're delighted to have them on board. They coined the term ‘behavioural insights’ in 2010 to help bring together ideas from a range of inter-related academic disciplines (behavioural economics, psychology, and social anthropology). These fields seek to understand how individuals take decisions in practice and how they are likely to respond to options. Their insights enable us to design policies or interventions that can encourage, support and enable people to make better choices for themselves and society.
BaseKit is the most widely deployed website editor distributed by hosting, telco and internet companies. Their hosting partners benefit from improved ARPU, reduced churn and higher customer satisfaction ratings. Supported configurations include On-premise, SaaS, cPanel plugin and Parallels APS. Their application and documentation is available in 16 languages.
Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation of clots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients.
Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countries to prevent fraud and financial crime. ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.
Playmob is a game platform for brands with a purpose. They connect the most meaningful brands to billions of mobile gamers, to take action and make the world a better place while positively boosting the brand's bottom line.
Harnessing the power of novel light-harvesting polymeric materials, Sirigen’s amplification technology offers High Sensitivity Fluorescence™ (HSF™) detection to the Diagnostic and Life Science marketplaces. Sirigen’s versatile and HSF™ technology simplifies sample processing and instrumentation requirements in both immunodiagnostic and nucleic acid based applications, and facilitates high volume screening in theradiagnostics and other personal care applications.
Skimlinks is the leading commerce content monetization platform, supporting publishers’ creation of a new revenue stream that allows them to be less dependent on advertising. Commerce can contribute as much as a quarter of publishers’ overall revenue. Skimlinks technology automatically earns publishers a share of sales they drive through monetized product links in commerce-related content. These links generate revenue when clicked on by readers who go on to make a purchase as a result. In its platform, Skimlinks offers a growing suite of innovative solutions designed to increase the number of clicks and earnings per click of commerce-related content. It also aggregates access for publishers to over 60 affiliate networks, enabling them to earn commission from 27,000 merchants around the world instantly. Annual ecommerce transactions in Skimlinks’ network totalled $1 billion in 2017. Clients include over half of the top 100 US & UK publishers by revenue including Conde Nast, Hearst, Buzzfeed, Huffington Post, Trinity Mirror, MailOnline, and more.
Harnessing the power of novel light-harvesting polymeric materials, Sirigen’s amplification technology offers High Sensitivity Fluorescence™ (HSF™) detection to the Diagnostic and Life Science marketplaces. Sirigen’s versatile and HSF™ technology simplifies sample processing and instrumentation requirements in both immunodiagnostic and nucleic acid based applications, and facilitates high volume screening in theradiagnostics and other personal care applications.
Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation of clots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients.
Cellnovo Group SA is a medical technology company based in Paris, France, that focuses on developing and marketing innovative mobile diabetes management systems. Its flagship product includes a cordless micro-pump for insulin administration, an integrated activity monitor, and a cellular-enabled wireless touchscreen handset that connects securely to servers for real-time data access. This system allows users to manage insulin injections effectively while enabling family members and healthcare professionals to monitor the patient's condition remotely. The company aims to empower individuals with diabetes by providing tools that simplify management and enhance their quality of life. Cellnovo markets its products through a direct sales force in the United Kingdom and France, as well as through international distributors. Additionally, it has partnered with Diabeloop SA to develop an artificial pancreas solution, further expanding its commitment to innovative diabetes care. The company was incorporated in 2014 and seeks to transform diabetes management through thoughtful design and modern technology.
Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation of clots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients.
Kaptivo uses AI to make visual collaboration easier and more efficient. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. Businesses and schools use Kaptivo in conjunction with Zoom, Cisco Webex, Microsoft Teams, Slack and other collaboration tools to improve productivity while keeping content secure.
Harnessing the power of novel light-harvesting polymeric materials, Sirigen’s amplification technology offers High Sensitivity Fluorescence™ (HSF™) detection to the Diagnostic and Life Science marketplaces. Sirigen’s versatile and HSF™ technology simplifies sample processing and instrumentation requirements in both immunodiagnostic and nucleic acid based applications, and facilitates high volume screening in theradiagnostics and other personal care applications.
eoSemi is an emerging privately-funded semiconductor product company based in South Yorkshire. Shrinking electronic systems are placing significant pressure on traditional timing and frequency devices to reduce in size without compromising performance - something they cannot do easily or cheaply. eoSemi is a new technological transformation. It meets head-on the challenges of size-vs-performance, with an enabling technology that allows for creation of far more compact designs, and that facilitates new classes of product and application.
BaseKit is the most widely deployed website editor distributed by hosting, telco and internet companies. Their hosting partners benefit from improved ARPU, reduced churn and higher customer satisfaction ratings. Supported configurations include On-premise, SaaS, cPanel plugin and Parallels APS. Their application and documentation is available in 16 languages.
Aquapharm is an innovative drug discovery company focussed on developing new products founded on the chemical diversity of marine micro-organisms. Their core focus is the development of novel pharmaceutical compounds leading to the development of novel antibiotics, targeting both Gram negative and Gram positive infections. In addition, Aquapharm's development pipeline is also fed by an active discovery portfolio of anti-oxidants, anti-inflammatories and novel biocatalysts.
Veryan was formed in 2003 as the result of a technology spin out from Imperial College, London, UK. Veryan has designed, patented and developed a highly innovative three dimensional (3D) Nitinol (nickel-titanium alloy) stent technology – BioMimics 3D – based on the pioneering work by Professor Colin Caro (Emeritus Professor of Physiological Mechanics, Dept. of Bioengineering, Imperial College London) on the link between vessel geometry, blood flow mechanics and vascular disease.
Skimlinks is the leading commerce content monetization platform, supporting publishers’ creation of a new revenue stream that allows them to be less dependent on advertising. Commerce can contribute as much as a quarter of publishers’ overall revenue. Skimlinks technology automatically earns publishers a share of sales they drive through monetized product links in commerce-related content. These links generate revenue when clicked on by readers who go on to make a purchase as a result. In its platform, Skimlinks offers a growing suite of innovative solutions designed to increase the number of clicks and earnings per click of commerce-related content. It also aggregates access for publishers to over 60 affiliate networks, enabling them to earn commission from 27,000 merchants around the world instantly. Annual ecommerce transactions in Skimlinks’ network totalled $1 billion in 2017. Clients include over half of the top 100 US & UK publishers by revenue including Conde Nast, Hearst, Buzzfeed, Huffington Post, Trinity Mirror, MailOnline, and more.
Lein Applied Diagnostics is an optical metrology company pioneering measurement devices and solutions for the healthcare and industrial markets. Its core technology is based around a scanning confocal system that can make highly precise, non-contact dimensional and structural measurements of organic and man-made materials. Lein was founded in 2003, initially to develop a non-invasive, pain free glucose meter for the diabetes market. Underpinning this Lein put together a highly qualified, experienced engineering team and built up a strong suite of patents.
Plaxica is a technology and licensing company focused on the production of next generation biopolymers and platform chemicals from renewable resources. It was founded in 2008 and is based in London and Wilton.
BaseKit is the most widely deployed website editor distributed by hosting, telco and internet companies. Their hosting partners benefit from improved ARPU, reduced churn and higher customer satisfaction ratings. Supported configurations include On-premise, SaaS, cPanel plugin and Parallels APS. Their application and documentation is available in 16 languages.
Kaptivo uses AI to make visual collaboration easier and more efficient. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. Businesses and schools use Kaptivo in conjunction with Zoom, Cisco Webex, Microsoft Teams, Slack and other collaboration tools to improve productivity while keeping content secure.
Smart Surgical Appliances
Seed Round in 2009
Smart Surgical Appliances is a medical device company that develops sensor-enabled surgical instruments designed to reduce costs, improve safety, and minimize risk in keyhole surgery. The company intends to improve the safety and clinical efficacy of the minimally invasive surgery like keyhole surgery, endoscopic surgery, and the natural orifice transluminal endoscopic surgeries. It provide real-time sensing and feedback from the operative site akin to 'touch and feel'.
Skimlinks is the leading commerce content monetization platform, supporting publishers’ creation of a new revenue stream that allows them to be less dependent on advertising. Commerce can contribute as much as a quarter of publishers’ overall revenue. Skimlinks technology automatically earns publishers a share of sales they drive through monetized product links in commerce-related content. These links generate revenue when clicked on by readers who go on to make a purchase as a result. In its platform, Skimlinks offers a growing suite of innovative solutions designed to increase the number of clicks and earnings per click of commerce-related content. It also aggregates access for publishers to over 60 affiliate networks, enabling them to earn commission from 27,000 merchants around the world instantly. Annual ecommerce transactions in Skimlinks’ network totalled $1 billion in 2017. Clients include over half of the top 100 US & UK publishers by revenue including Conde Nast, Hearst, Buzzfeed, Huffington Post, Trinity Mirror, MailOnline, and more.
Camrivox Ltd offers customers simple and effective Telephony Integration with CRM. The company has pioneered the development and delivery of Flexor Software, greatly simplifying CRM Telephony Integration that has traditionally relied upon large investments in infrastructure, hardware and support staff. With Flexor Software uniquely delivered and supported at the PC level, companies can bypass this resource-laden route, improving business processes and increasing customer satisfaction. Camrivox, founded in 2005, is headquartered in Cambridge, UK.
Skimlinks is the leading commerce content monetization platform, supporting publishers’ creation of a new revenue stream that allows them to be less dependent on advertising. Commerce can contribute as much as a quarter of publishers’ overall revenue. Skimlinks technology automatically earns publishers a share of sales they drive through monetized product links in commerce-related content. These links generate revenue when clicked on by readers who go on to make a purchase as a result. In its platform, Skimlinks offers a growing suite of innovative solutions designed to increase the number of clicks and earnings per click of commerce-related content. It also aggregates access for publishers to over 60 affiliate networks, enabling them to earn commission from 27,000 merchants around the world instantly. Annual ecommerce transactions in Skimlinks’ network totalled $1 billion in 2017. Clients include over half of the top 100 US & UK publishers by revenue including Conde Nast, Hearst, Buzzfeed, Huffington Post, Trinity Mirror, MailOnline, and more.
Dexela develops a 3-D breast imaging technology for the early detection of breast cancer. It offers DexTop Digital Mammography Workstation, a screening workstation that ensures screening workflow and performance; and Dexela 3D reconstruction engine that is offered to OEM partners as a software module with licensing terms. The company provides flat panel CMOS X-ray detectors that are used in various medical applications, including mammography and tomosynthesis, breast CT, dental CBCT, fluoroscopy, cardiology and angiographic imaging, and bone densitometry, as well as in scientific instrumentation and non-destructive testing applications. It also offers consulting services in the areas of digital tomosynthesis, mammography acquisition geometry, and optimal reconstruction of 3D data; and design and implementation resources for hardware and software engineering projects. Dexela Limited was incorporated in 2003 and is based in London, the United Kingdom. It has an X-ray research and development facility in Sudbury, Massachusetts.
MMIC Solutions is deploying technology to allow the commercial use of high frequencies in the millimeter wave bands. The company develops, manufactures, and supplys innovative solutions for a range of systems operating at frequencies between 50GHz and 250GHz
Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation of clots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients.
Micrima Ltd. spun out from research at the University of Bristol. The Micrima team is developnig radio-wave technology for detecting breast cancer. The technology is non-invasive, non-ionising and inexpensive. The imaging technology has received extensive validation in the laboratory and is now undergoing first human use trials.
Gnodal was founded in 2007 by a world-class team of IT infrastructure design experts with a proven track record for delivering best-of-breed networking systems that meet the demands of their customers. The team's experience and collaborative spirit in working together on design, manufacture and deployment, has led to the definition of a technology that is revolutionizing the data center. Gnodal is building the largest, fastest, most efficient and scalable technology in the world for the high performance data center.
ProVision was founded by two university professors, each renowned in the wireless and video fields as world experts. This gives ProVision a unique technological advantage. As a result the company is able to create products that reliably display HD video, regardless of fluctuations in the wireless signal caused by people moving within the home, and the size and structure of the home. ProVision’s two main technology platforms are AXAR, a system for all-room wireless distribution of HDTV to televisions in homes, and ProMultiVu, a technology for multi-cast video transmission at outdoor events. ProMultiVu transmissions are typically received by laptop PCs, PDAs or smart phones.
Cellnovo Group SA is a medical technology company based in Paris, France, that focuses on developing and marketing innovative mobile diabetes management systems. Its flagship product includes a cordless micro-pump for insulin administration, an integrated activity monitor, and a cellular-enabled wireless touchscreen handset that connects securely to servers for real-time data access. This system allows users to manage insulin injections effectively while enabling family members and healthcare professionals to monitor the patient's condition remotely. The company aims to empower individuals with diabetes by providing tools that simplify management and enhance their quality of life. Cellnovo markets its products through a direct sales force in the United Kingdom and France, as well as through international distributors. Additionally, it has partnered with Diabeloop SA to develop an artificial pancreas solution, further expanding its commitment to innovative diabetes care. The company was incorporated in 2014 and seeks to transform diabetes management through thoughtful design and modern technology.
CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga. The programme also has potential clinical utility in non-small cell lung, breast and colon cancer.
Kaptivo uses AI to make visual collaboration easier and more efficient. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. Businesses and schools use Kaptivo in conjunction with Zoom, Cisco Webex, Microsoft Teams, Slack and other collaboration tools to improve productivity while keeping content secure.
Aquapharm is an innovative drug discovery company focussed on developing new products founded on the chemical diversity of marine micro-organisms. Their core focus is the development of novel pharmaceutical compounds leading to the development of novel antibiotics, targeting both Gram negative and Gram positive infections. In addition, Aquapharm's development pipeline is also fed by an active discovery portfolio of anti-oxidants, anti-inflammatories and novel biocatalysts.
Veryan was formed in 2003 as the result of a technology spin out from Imperial College, London, UK. Veryan has designed, patented and developed a highly innovative three dimensional (3D) Nitinol (nickel-titanium alloy) stent technology – BioMimics 3D – based on the pioneering work by Professor Colin Caro (Emeritus Professor of Physiological Mechanics, Dept. of Bioengineering, Imperial College London) on the link between vessel geometry, blood flow mechanics and vascular disease.
Symetrica Ltd. engages in the development and commercialization of radiation detection and identification systems for security, medical diagnostics, geophysical, and space research and development applications. The company was incorporated in 2002 and is based in Southampton, the United Kingdom.
MMIC Solutions is deploying technology to allow the commercial use of high frequencies in the millimeter wave bands. The company develops, manufactures, and supplys innovative solutions for a range of systems operating at frequencies between 50GHz and 250GHz
Kaptivo uses AI to make visual collaboration easier and more efficient. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. Businesses and schools use Kaptivo in conjunction with Zoom, Cisco Webex, Microsoft Teams, Slack and other collaboration tools to improve productivity while keeping content secure.
CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga. The programme also has potential clinical utility in non-small cell lung, breast and colon cancer.
Micrima Ltd. spun out from research at the University of Bristol. The Micrima team is developnig radio-wave technology for detecting breast cancer. The technology is non-invasive, non-ionising and inexpensive. The imaging technology has received extensive validation in the laboratory and is now undergoing first human use trials.
Veryan was formed in 2003 as the result of a technology spin out from Imperial College, London, UK. Veryan has designed, patented and developed a highly innovative three dimensional (3D) Nitinol (nickel-titanium alloy) stent technology – BioMimics 3D – based on the pioneering work by Professor Colin Caro (Emeritus Professor of Physiological Mechanics, Dept. of Bioengineering, Imperial College London) on the link between vessel geometry, blood flow mechanics and vascular disease.
Symetrica Ltd. engages in the development and commercialization of radiation detection and identification systems for security, medical diagnostics, geophysical, and space research and development applications. The company was incorporated in 2002 and is based in Southampton, the United Kingdom.
CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga. The programme also has potential clinical utility in non-small cell lung, breast and colon cancer.
By bridging the research to industry innovation gap, Water Innovate overcomes major obstacles that have existed in the water and environmental industries for too long. Water Innovate has assembled a technology pipeline that is transferring ground-breaking environmental technologies from research labs into the marketplace. Water Innovate clearly identifies and exploits routes to market by evaluating new technologies and investing significant resources in their development. A range of exciting technologies developed by leading experts in water and wastewater treatment are available. These can be viewed in our Product Datacentre by selecting the links on the left or the drop down menu on the right.
NanoSight was formed in 2002 to develop nanoparticle detection techniques based on a suite of patents that came out of the work of its founder and current Chief Technical Officer, Bob Carr. It is now the world leading provider of a series of unique instruments for the optical detection and real time analysis of sub-micron particles that offer significant advantages compared to existing light scattering techniques.
Tideway Systems provides a shared platform for technologists to visualize and report on the data they need to make informed decisions. Tideway Foundation software continuously maps application relationships to physical and virtual infrastructure, including the dependencies between them.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.